Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Proto Labs, Inc. PRLB

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.

Insider Decisions

Total sells
2.44
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy
Sell 1 2 2 1
Insider Ownership
1.71%

Capital & Financial Ratios

Market Cap
2,070.00
Revenue
560.54
Net Income
30.48
Free Cash Flow
58.78
Net Debt
(142.78)
Current Ratio
3.64
Debt/Equity
0.00
P/E ratio
69.09
P/S ratio
3.75
P/B ratio
3.04
Past 5Y EPS Growth
(22.50%)
This Y EPS Growth
33.37%
Next Y EPS Growth
7.84%
Next 5Y EPS Growth
5.79%
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
Annual Dividend Yield
total individual payouts
2024 ‡‡‡
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
2020 ‡‡‡
2019 ‡‡‡
2017 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 102.80 103.09 128.12 142.78
Receivables 75.08 69.41 81.43 96.46
Inventory 13.66 12.31 14.40 15.41
Other
200.66 194.85 233.54 266.24
2023 2024 2025 Q'26
Payables 15.64 15.50 15.10 21.54
ST’ Debt
Other
49.68 53.27 67.00 73.20
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 139.34 149.34
’25 126.21 135.06 135.37 136.49
533.13
’24 127.89 125.63 125.62 121.75
500.89
’23 125.86 122.27 130.71 125.05
503.88
’22 124.17 126.90 121.72 115.61
488.40
’21 116.13 123.05 125.34 123.58
488.10
’20 115.11 106.58 107.50 105.21
434.40
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 17.54 15.44
’25 18.38 10.58 29.09 16.45
74.50
’24 21.34 14.44 24.75 17.29
77.83
’23 22.58 9.29 24.18 17.23
73.27
’22 17.78 13.26 20.52 10.52
62.08
’21 6.43 14.30 11.50 23.02
55.24
’20 22.41 31.01 28.96 24.59
106.97
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 15.28 9.24
’25 17.12 9.12 25.84 8.42
60.50
’24 18.77 10.25 23.20 16.46
68.69
’23 19.33 6.33 21.14 (0.95)
45.86
’22 14.71 10.30 13.37 6.12
44.50
’21 (0.12) (3.08) 7.47 16.76
21.03
’20 8.99 11.12 21.77 18.07
59.96
in millions of $

EPS

Mar Jun Sep Dec Year
’26 0.33 0.37
’25 0.15 0.18 0.30 0.25
0.88
’24 0.20 0.18 0.29 (0.02)
0.66
’23 0.10 (0.01) 0.31 0.27
0.66
’22 0.19 0.09 0.14 (4.24)
(3.77)
’21 0.13 0.47 0.17 0.43
1.21
’20 0.52 0.47 0.55 0.36
1.89

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

1.4
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 22.04 23.01 25.76 29.59
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 61.14 40.47 45.15 55.90
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,568 2,415 2,357 2,280
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.19 0.21 0.21 0.23
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 488.40 503.88 500.89 533.13 ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 44.12% 44.06% 44.56% 44.48%
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (97.88) 27.95 24.67 31.06
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (20.04%) 5.55% 4.93% 5.83% ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (103.46) 17.22 16.59 21.24 ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 39.43 37.53 35.81 33.81
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 17.82 19.24 19.96 22.29 ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡ ‡‡‡‡ (3.77) 0.66 0.66 0.89 ‡‡‡‡‡ ‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.26 2.80 3.10 3.11
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.64) (1.05) (0.36) (0.59) ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.62 1.75 2.74 2.53
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 25.45 26.55 26.70 28.17
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27.41 26.19 25.10 23.92 ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.00 56.72 59.23 56.84 ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.42 1.97 1.96 2.27 ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.99 1.43 1.46 1.80 ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.30 1.81 1.79 2.06 ‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 14.26 19.87 13.05 18.19
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 62.08 73.27 77.83 74.50 ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (17.58) (27.42) (9.13) (14.01)
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 44.50 45.86 68.69 60.50
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 114.99 150.98 141.58 166.54
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 21.35 0.60 0.29
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (58.77) (102.21) (102.80) (128.12)
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 697.65 695.30 670.15 673.93
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (11.96%) 2.19% 2.19% 2.82%
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (9.59%) 2.97% 2.19% 2.88%
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (13.56%) 2.47% 2.43% 3.16%
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Proto Labs (PRLB), a pioneer in on-demand digital manufacturing, shows resilient recovery with revenue approaching $500 million annually and strong free cash flow per share surging 56% to $2.74 in 2024, fueled by workforce optimization and the asset-light Hubs network acquired in 2021. Despite gross margin compression to 45% from pandemic-era highs and a volatile history—including a 92% stock plunge in 2022—recent insider buys by the CEO and a director signal executive confidence amid stabilizing ROIC at 2.2% and a pristine $103 million net cash position.

Trading at a 23% premium to analyst mean targets, PRLB’s forward projections dazzle with 6.6% revenue CAGR to $607 million by 2026, EPS climbing 22% to $1.42, and potential ROIC expansion to 5%+ from Hubs synergies and AI manufacturing tailwinds. Yet, high P/E ratios and margin risks from supply chain frictions warrant caution, as statistical models flag 25% odds of growth faltering below 5%. This balanced thesis—overweight for patient investors eyeing 20-30% EPS upside—unpacks deeper correlations and probabilistic edges in the full analysis.

Proto Labs, Inc. (PRLB) Latest News

News by impact score

Fine-tune

5 Sep

3 , 8:12 AM
Proto Labs (PRLB) appears 15% undervalued after a leadership change and positive Business Insider recognition. Leadership transition and external positive coverage may moderately shift investor sentiment and valuation.

3 , 6:11 AM
Proto Labs appoints new COO and earns innovation accolade, potentially altering its bull case and investor outlook. COO appointment and innovation accolade may affect operations and sentiment but lack scale to fundamentally shift company trajectory.

11 Aug

3 , 4:09 PM
Proto Labs raised 2026 revenue guidance and highlighted rising customer spend, driving an 11.7% stock gain. Raising 2026 guidance and noting higher customer spend point to improved near-term revenue visibility without altering core operations.

9 Aug

3 , 8:05 PM
Proto Labs held its Q2 earnings call covering financial results and business updates, with analysts directing five primary questions at management on operational performance, demand trends, and strategic outlook. Q2 earnings call and analyst questions offer incremental visibility into near-term results without indicating major strategic shifts or transformative events.

7 Aug

3 transcript www.fool.com, 10:44 PM
Proto Labs (PRLB) held its Q2 2026 earnings call, covering quarterly financial results, operational updates and forward guidance. Quarterly earnings calls deliver financial metrics and guidance that can shift near-term investor sentiment and valuation.

31 Jul

4 , 5:02 PM
Proto Labs Inc posted record revenue for Q2 2026 and raised its financial guidance. Record revenue and raised guidance point to strong results that can materially lift stock performance and investor outlook.

4 , 6:14 AM
Proto Labs posted strong Q2 CY2026 results and issued encouraging quarterly revenue guidance. Strong earnings beat plus positive guidance directly lifts near-term revenue outlook and investor sentiment.

3 transcript www.marketbeat.com, 8:03 PM
Proto Labs Q2 earnings call highlights financial results and company performance for the quarter. Q2 earnings metrics typically influence PRLB stock price and short-term investor sentiment.

3 , 6:00 AM
Proto Labs reported financial results for the second quarter of 2026. Quarterly earnings release reveals performance metrics that may shift near-term stock sentiment without indicating major strategic shifts.

30 Jul

3 , 10:45 AM
Proto Labs (PRLB) is scheduled to report earnings tomorrow. Earnings release may moderately move Proto Labs stock and investor views.

10 Jul

3 , 10:10 PM
Proto Labs (PRLB) lands on TIME list while expanding operations to meet rising drone demand. TIME list placement and drone-sector expansion provide moderate visibility and growth potential without altering core trajectory.

7 Jul

3 , 9:00 AM
Proto Labs accelerates growth and drone innovation with on-demand manufacturing capabilities. On-demand manufacturing capabilities directly support Proto Labs growth and drone innovation.

23 Jun

3 StockStory, 8:16 AM
Proto Labs reported Q1 earnings, triggering buy, sell or hold assessments for PRLB stock based on financial results and outlook. Q1 earnings and buy-sell-hold analysis can shift near-term investor views and trading in PRLB shares.

10 Jun

3 Simply Wall St., 3:16 PM
Proto Labs appoints new Chief Commercial Officer alongside double-digit revenue growth, triggering fresh valuation review for the company. New CCO hire and double-digit revenue growth point to moderately noticeable effects on operations and market view without major trajectory shifts.

12 May

4 Simply Wall St., 1:08 AM
Proto Labs (PRLB) reported strong Q1 results and leadership changes, triggering a valuation reassessment amid positive financial momentum and strategic shifts. Strong Q1 results enhance financial performance while leadership changes introduce major strategic implications for competitive positioning.

11 May

3 StockStory, 9:40 PM
Analysts highlighted top five questions from Proto Labs' Q1 earnings call, probing performance metrics, growth strategies, operational challenges, and future outlook. Analyst questions from Q1 earnings call spotlight financial performance and strategic priorities with moderate influence on market sentiment.

7 May

3 Business Wire, 8:45 AM
Proto Labs, Inc. (PRLB) appointed Bernardo Parlange as Chief Commercial Officer to strengthen its executive leadership team. New Chief Commercial Officer appointment targets enhanced sales strategy and market positioning with moderately noticeable influence.

4 May

4 StockStory, 12:04 AM
Proto Labs (PRLB) Q1 results showcase strategic customer wins, operational reset, and expansion plans, sparking mixed market reaction. Strategic customer acquisitions, operational reset, and expansion initiatives represent major moves likely to reshape PRLB's trajectory and investor outlook.

3 Simply Wall St., 7:11 PM
Proto Labs reports record CNC quarter but cautious 2026 guidance, with analysis on potential investor reactions amid mixed signals for future growth. Record CNC results signal operational strength, but cautious 2026 outlook tempers investor enthusiasm and financial trajectory.

2 May

4 www.marketbeat.com, 6:35 AM
Proto Labs released Q1 earnings call highlights, detailing financial results, operational performance, growth strategies, and future outlook. Q1 earnings highlights cover financial metrics, guidance, and strategic updates with potential to significantly sway investor sentiment and stock performance.

4 GuruFocus.com, 3:01 AM
Proto Labs reported record revenue in Q1 2026 earnings call, driven by strategic growth in core operations, expanded capabilities, and market expansion initiatives. Record revenue and strategic growth directly enhance financial performance and competitive positioning.

1 May

4 transcript www.fool.com, 2:23 PM
Proto Labs (PRLB) released Q1 2026 earnings call transcript covering financial results, operational updates, and forward guidance. Q1 2026 earnings transcript details financial performance and strategic outlook likely to significantly sway investor sentiment and stock trajectory.

4 , 7:10 AM
Proto Labs (PRLB) surpassed Q1 earnings and revenue estimates. Surpassing Q1 earnings and revenue estimates boosts investor sentiment and signals strong financial performance, significantly impacting future market trajectory.

4 StockStory, 7:04 AM
Proto Labs (NYSE:PRLB) reported better-than-expected sales in Q1 CY2026. Exceeding Q1 2026 sales expectations signals strong operational performance and boosts investor sentiment for PRLB.

4 Business Wire, 6:00 AM
Proto Labs, Inc. (PRLB) reported financial results for Q1 2026. Quarterly financial results disclosure significantly influences PRLB's stock price, investor sentiment, and future performance projections.

3 app.moby.co, 4:49 PM
Proto Labs, Inc. (PRLB) released Q1 2026 earnings call summary highlighting financial results, operational updates, and forward guidance. Quarterly earnings summaries affect financial performance and investor sentiment but are balanced by ongoing operations.

3 Barrons.com, 10:59 AM
Proto Labs' AI-enabled manufacturing business booms with solid earnings, yet shares fail to rise amid market concerns. Booming AI-driven operations and strong earnings offer moderate growth potential balanced by stagnant share performance.

9 Apr

3 Business Wire, 10:22 AM
Proto Labs, Inc. (PRLB) joins the Space Foundation as a corporate member to support aerospace innovation and manufacturing in the new space age. Partnership positions Proto Labs for moderate growth in the expanding aerospace sector through enhanced industry connections.

6 Apr

3 Simply Wall St., 1:08 AM
Analyst upgrades and strong Zacks Rank rating trigger valuation assessment for Proto Labs (PRLB), highlighting potential upside in stock performance. Analyst upgrades and strong Zacks Rank positively influence investor sentiment and market performance moderately.

5 Apr

3 Simply Wall St., 9:15 PM
Proto Labs (PRLB) receives earnings upgrade and Zacks Rank shift, poised to positively influence investor sentiment and stock performance. Earnings upgrade and Zacks Rank shift signal improved analyst expectations for financial performance, providing moderate boost to market trajectory.

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us